- DKK20.84bn
- DKK20.71bn
- DKK6.04bn
Brief: Ambu Obtains Regulatory Clearances For Expanded GI Indication
UBS turns cautious on Ambu's targets, cuts to 'neutral'
Brief: Ambu Acquires TIMS Medical To Advance Endointelligence
Brief: Ambu Reports Q3 EBIT DKK 221 Mln
Brief: Ambu Updates Financial Outlook For 2025/26
Brief: Ambu Expands Neurology Portfolio In U.S. And Europe
Brief: Ambu Starts New Share Buyback Program
Brief: Ambu Q2 Organic Revenue Growth 7.3%
Brief: Ambu Share Buyback Program Ends
Europe Research Roundup: Equinor, HSBC , RWE
Brief: Ambu Q1 EBIT Ex-Items Slumps To DKK 164 Mln
Ambu dives to the bottom of STOXX on EBIT miss, new guidance
Brief: Ambu Expects Organic Revenue Growth Of 10-13% In 2025/26
Factbox: Who's on Novo Nordisk's board after major shakeup?
European shares close at record high as healthcare outperforms; US shutdown in focus (updated)
Refile: BUZZ-'Overall a relief': TrumpRx price cuts deals boost European pharma stocks
European healthcare stocks surge as US deal with Pfizer reduces some uncertainty (updated)
European healthcare stocks surge as U.S. Pfizer deal reduces some uncertainty
Ambu jumps as long term targets bring relief